Table 1 Clinical characteristics and treatments - Crohn’s disease patients at the time of study inclusion. Values are given as the mean (minimum-maximum) for continuous variables and numbers (%) for categorical variables
Quiescent Crohn’s disease | Active Crohn’s disease | Controls | |
|---|---|---|---|
Cases | 15 | 15 | 15 |
Age, years | 36 (18–63) | 37 (21–76) | 55 (38–76) |
Sex female/male | 9/8 | 11/4 | 4/11 |
Age at diagnosis, years | 30 (19–60) | 26 (15–58) | |
Duration of the disease, years | 7 (1–21) | 12 (1–26) | |
Current treatment | |||
No medication | 1 (7 %) | 5 (33 %) | |
5-ASA/Salazopyrin/Azathioprine | 2 (17 %) | 2 (17 %) | |
Corticosteroids/immunosuppressants | 9 (60 %) | 6 (40 %) | |
Infliximab | 8 (53 %) | 5 (33 %) |